Dyslipidemia & CVD 1 Flashcards
Guidelines to consult for dyslipidemia in Canada
The Canadian cardiovascular Society’s Dyslipidemia Guidelines
Trend of mortality from CVD in past decade
40% decrease in mortality from CVD
Why decrease in mortality from CVD
- improvement in control of CVD risk factors
- medical management of patients with CVD
2nd cause of death
CVD (1st= cancer)
Role of cardiovascular system
- regulates blood flow to tissues
- thermoregulation
- hormone transport
- maintenance of fluid volume
- regulation of pH
- gas exchange
How the cv system regulates blood flow to tisses
- delivers oxygenated blood and nutrients
- retrieves waste products
Major forms of cardiovascular disease
- hypertension
- atherosclerosis
- coronary heart disease
- peripheral vascular disease (cerebrovascular disease; deep vein thrombosis)
- congestive heart failure
Atherosclerosis =
Thickening of the blood vessel walls caused by presence of atherosclerotic plaque
Atherosclerosis results in :
restriction of arterial blood flow (due to the plaque)
Atherosclerosis is associated with :
- myocardial infarction (MI°
- cerebrovascular accident (CVA or stroke)
- peripheral vascular disease (PVD)
- coronary heart disease (CHD)
- congestive heart failure (CHF) when severe CHD or MI occurs
Cells involved in atherosclerosis
- endothelial cells
- smooth muscle cells
- platelets
- leukocytes
How atherosclerosis begins
Begins as a response to endothelial lining injury that results in an inflammatory process
Symptoms of atherosclerosis
asymptomatic until it progresses to ischemic heart disease
3 steps of formation of atherosclerotic plaque
1) Injury of endothelial wall, monocytes respond to injury and infiltration under the lining
2) Monocytes slip under blood vessel cells and engulf LDL cholesterol, becoming foam cells. Fatty streaks develop.
3) fatty streak thickens and forms plaque as it accumulates additional lipids, smooth muscle, CT, cellular debris
Key cells that react to endothelial injury
monocytes = phagocytic WBC
What are fatty streaks
the thin layer of foam cells that develop on artery walls
Primary causes of endothelial wall damage
- high blood pressure
- chemicals from tobacco
- oxidized LDL
- glycated proteins
- low nitric oxide
- angiotensin2
In which disease would you have glycated proteins
Uncontrolled diabetes leads to chronic hyperglycaemia in circulation
Consequence of decreased nitric oxide
vasoconstriction
2 hypothesis that used to describe the atherogenesis (discovered they are linked)
- Endothelial-Injury hypothesis
2. Lipid-infiltration hypothesis
Endothelial-Injury hypothesis
endothelial injury -> adherence of platelets -> release of platelet-derived growth factor-> cell proliferation -> advanced lesion (atheroma)
Lipid-infiltration hypothesis
high plasma LDL level -> LDL infiltration into intima -> oxidised LDL plus macrophages -> foam cells -> fatty streak
How are the 2 theories linked?
Oxidized LDL + macrophages and fatty streak both cause endothelial injury
T/F
High LDL causes foam cells and thus atherosclerosis
F
Need an injury to contribute to atherosclerosis
Biomarker of atherosclerosis
CRP
Risk factors for developing atherosclerosis
- family history
- age and sex (more in men, 65+)
- obesity (+ly associated with dyslipidemia, HTN, physical inactivity, diabetes)
- dyslipidemia
- hypertension
- physical inactivity
- diabetes mellitus
- impaired fasting glucose/metabolic syndrome
- cigarette smoke
- obstructive sleep apnea
Typical patient at high risk for atherosclerosis
- man
- 65+
- obese
- smokes
- physically inactive
Atherosclerosis less prevalent in women, why
Because estrogen is protective against atherosclerosis (post menopausal women have a risk similar to men)
Which risk factor for atherosclerosis can be revered?
Physical inactivity
How can hypertension be a risk for developing atherosclerosis
- may initiate an atherosclerotic lesion
- can cause plaque to rupture
Chylomicrons
lipoproteins formed by intestine after we ingest a meal with fat, are carriers of ingested TG
Enzyme that lines blood vessels and hydrolyses TG
Lipoprotein lipase
Apoprotein on VLDL
ApoB-100 (from liver)
Apo E
Apo C
Apoprotein on CM
Apo B-48 (from intestine) Apo A-I Apo A-IV Apo C-II Apo C-III
Apoprotein on HDL
Apo A-1
Apo A-II
Apo C
Apo E
Lipoprotein with the most TG
CM
Lipoprotein with the least TG
HDL
Lipoprotein with the most cholesterol esters
LDL
Lipoprotein with the most ApoP
HDL
Desirable range for total cholesterol
< 5.2 mmol/L
Normal HDL range
1.0 - 1.5 mmol/L
>1.0 men
>1.3 women
Optimal LDL range
< 2.6 mmol/L (but already is low)
Optimal TG range
< 1.7 mmol/L
Apoprotein Functions
- synthesis/secretion of specific lipoproteins
- stabilize coat of lipoprotein
- activate enzymes
- interact with cell surface receptors
apoC-II activates
LPL
LDL receptors react with which apoprotein
B-100
Apoproteins reflect
- changes in lipoprotein composition
- indicative of number of lipoproteins in plasma
Apoproteins used to diagnose what?
In diagnostic of lipoprotein disorders and risk for developing CHD or CVD
Apoproteins are predictors of what?
May be better predictors of heart disease than lipid levels and may correlate with the severity of the disease
Most common ApoE genotype (60% frequency)
E-3/E-3
carrier of double allele
Least common ApoE genotype (1% frequency)
E-2/E-2
What is unusual of Apo E-2/E-2
Does not bind to LDL receptors –> high VLDL remnants –> risk of dyslipidema
Primary (or Familial) dyslipidemia classification
Single or poly-genetic abnormalities affecting lipoprotein function resulting in hyperlipidemia or hypolipidemia
Secondary dyslipidemia classification
- environmental causes +/- predisposition
- happens later in life
- more prevalent
- due to other causes than genetic
How to diagnose primary dyslipidemia
- history (age at onset, family members)
- physical signs
- lab analysis
- appearance of serum
- genetic sequencing for rare cases
Physical signs of 1° dyslipidema
xanthomas
Lab analysis of 1° dyslipidema
lipid profile, apoproteins, LPL activity
Serum of 1° dyslipidemia
Appears white
2 types of Familial Dyslipidemias
- hypolipoproteinemia (rare
- hyperlipoproteinemias (common)
3 types of hypolipoproteinemia
- Abetalipoproteinemia
- Familial hypobetalipoproteinemia
- Familial alpha-lipoprotein deficiency (Tangier disease)
Abetalipoproteinemia
- Defect in apoprotein B synthesis
- No chylo, VLDl, LDL formed
- TAG accumulate in liver and intestine
Familial hypobetalipoproteinemia
LDL concentration is 10-50% of normal but chylomicron formation occurs
Familial alpha-lipoprotein deficiency
- Virtual absence of HDL (Apo-AI)
- CE accumulate in tissues
- Chylo, VLDL, LDL are normal
- Moderate hyper TG
5 phenotypes of hyperlipoproteinemia
I: high CM IIa: high LDL IIb: high LDL +VLDL III: high beta VLDL IV: high VLDL V: high Chylo + VLDL
Most prevalent phenotype
IV and IIB
Xanthomas are a symptom of which type of hyperlipoproteinemia
Type III
dysbetalipoproteinemia
Out of VLDL, LDL, TG which is he most atherogenic?
LDL
Are xanthomas reversible?
Yes
Lifestyle factors that cause secondary dyslipidemia
Diet (high: cholesterol, saturated fats, trans fats, sugars)
Alcohol
Smoking
Lack of physical activity
High cholesterol increase:
- Total cholesterol
- LDL-C
(HDL-C stays the same)
High saturated fats increase:
- Total cholesterol
- LDL-C
- HDL-C
High trans fats increase, decrease:
Increase:
- Total chol
- LDL-C
Decrease:
-HDL-C
Alcohol increases:
- HDL-C
- TG
Lack of physical activity increases, decreases:
Increase:
-TG
Decrease:
-HDL-C
Diseases that cause secondary dyslipidemia are
diabetes hypothyroidism renal failure obesity cholestasis chirrhosis myelomas Cushing syndrom
Medication that cause secondary dyslipidemia are:
thiazide diuretics beta-blockers corticosteroids estrogens progesterone benzodiazepine retinoic acid antiretroviral
Obesity effects on lipoprotein metabolism
Increased substrate flux to liver
Can be :
-Postprandial = due to excess kcal (lipids, carbs)
-Postabsorptive = due to high adipose tissue and hormone-sensitive lipase activity resulting in increased FFA flux to liver
Why is hormone-sensitive lipase activity high in obese
because of insulin resistance
What is associated with low HDL-C
- high BMI
- abdominal obesity
Association between abdominal/visceral fat and HDL
- strong association with HDL
- strong association in men and post-menopausal women
Relationship between BMI and HDL
Inverse linear relationship
- stronger association of BMI with HDL than LDL
Mechanisms associated with reduced HDL-C in obesity
- association with hyperTG (high VLDL -> high CETP -> high hepatic lipase -> liver uptake)
- increased uptake of HDL2 by adipocytes
- increased clearance of apoA1 –> HDL catabolism
Who should be screened for CVD?
- Men 40+
- Women 40+ (OR postmenopausal)
Patients with which conditions should be screened regardless of age?
- Clinical evidence of atherosclerosis
- Abdominal aortic aneurysm
- Diabetes mellitus
- Arterial HTN
- Cigarette smoking
- Clinical signs of dyslipidemia
- Family history of dyslipidemia or premature CVD
- Chronic kidney disease
- Obesity
- HIV infection
- Inflammatory disease
How to screen for all
- history and physical examination
- standard lipid panel
- nonHDLC
- glucose
- eGFR
optional:
- ApoB
- urine albumin:creatinine ratio
Is fasting required for lipid testing ?
No
2016 recommendations for a CV risk assessment ?
- Every 3-5 years for men and women age 40-75
- OR when risk status changes
Framingham risk score
= estimation of 10-year cardiovascular disease risk
Important risk factors the FRS uses
- Sex
- Age
- HDL chol
- Total chol
- Blood pressure
- Diabetes
- Smoking
Important risk factors the FRS uses to predict CVD
- Sex
- Age
- HDL chol
- Total chol
- Blood pressure
- Diabetes
- Smoking
Why are TG not part of risk assessment
they are not very atherogenic
How to interpret the FRS
3 risk levels:
- High (20%+)
- Intermediate (10-19%)
- Low (10%-)
Statin should be prescribed in which cases
- clinical atherosclerosis
- abdominal aortic aneurysm
- LDL-C > 5mmol/L
-chronic kidney disease - diabetes IF
age 40+ OR
age 30+ and 15y duration OR
Microvascular disease